Scioto Biosciences
About:
Scioto is a developer of Activated Bacterial Therapeutics platform.
Website: http://sciotobiosciences.com
Top Investors: National Institutes of Health, BioCrossroads, Genome & Co., Rev1 Ventures, Pathway Bioventures
Description:
Scioto Biosciences is a developer of Activated Bacterial Therapeutics (ABT) platform intended to deliver live bacteria to the gut. The company is developing innovative therapies devoted to having a transformative impact on the delivery of microbiome therapeutics, enabling medical practitioners to advance healing through microbiome therapeutics.
$31M
$1M to $10M
Indianapolis, Indiana, United States
2017-01-01
James Schulz, Joseph Trebley
11-50
2020-08-10
Private
© 2025 bioDAO.ai